Eyecare
We offer deep expertise in science and technology, unrivalled agility in execution, and an excellent track record in developing new products and technology for clients in the eyecare market.
Technology with an eye to the future
Your core technology in diagnostics and monitoring realised
Imaging, other sensing technologies and digital analytics give clinicians unprecedented insight into disease progression and can motivate patients to adhere to their treatment. Working with clients in industry and healthcare settings, TTP’s Eyecare team translates these fast advancing technologies into novel products.
We are now enabling the next generation of ophthalmic diagnostics by developing devices for different care settings, including the home; by developing digital tools to support clinical decision making; and by inventing novel technologies to track eye disease.
The next inserter, implant or surgical tool for your market
Creating the next innovation in ophthalmic surgery can be a challenge. Success will depend on understanding patient needs and surgeon preferences, market insight and deep technical expertise.
We have developed and delivered across glaucoma, cataract, retina and refractive. Whether you want to improve an existing device, de-skill a procedure, or develop an entirely new device, TTP’s Eyecare team will bring application-specific know-how alongside physics, engineering and human-factors expertise. Where necessary, we call on medical device expertise from across TTP to add the skillsets needed to rapidly realise the ambitions of our innovative clients.
You formulate, we deliver
Whether you’re targeting a specific part of the eye, need a device for an upcoming clinical study, or want to manufacture at scale, our experienced engineers and scientists work with clients in ophthalmic pharma to take formulations from bench to bedside.
In recent years, we have supported clients by delivering projects ranging from de novo product development to late-stage device refinement. We’ve worked on intraocular inserters and topical, intraocular, suprachoroidal and sub-retinal delivery systems. Alongside devices, we’ve helped clients to scale their innovations by developing novel manufacturing processes for pharmaceutical products.
News & Insights
De-risking drug injection into the eye for Ripple Therapeutics
Ripple Therapeutics and TTP have worked together on a series of projects to advance intraocular drug delivery. TTP’s eyecare and medical device experts rapidly developed and evaluated several concepts for securing, and safely releasing, delicate drug implants in intravitreal drug injector devices.
Optical design for non-invasive intra-cranial pressure monitor
Third Eye Diagnostics wanted to measure the pressure inside the skull with a device that uses the eye as a window to the brain. Doing so could have huge benefits for patients.
Refining the consistency of advanced drug delivery to the eye
Gyroscope wanted to refine the fluidic control elements of its innovative Orbit™ Subretinal Delivery System (Orbit SDS™) medical device, which enables precise microinjection into the subretinal space of the eye.
Beyond the eyedropper bottle – Three ways to improve adherence
Nathan Wilkinson, Catherine Wyman, and Matt Parker discuss the future outlook of ophthalmic drug delivery beyond the traditional eyedropper bottle, including new delivery technologies, sustained release therapeutics and digital healthcare applications.
Technology to meet the growing demand for cataract surgery
Health Tech Consultant, Nathan Wilkinson, explores how technology can improve efficiency in cataract surgery before focusing on some of the opportunities for streamlining diagnostics and surgery.